interferoninduc
ubiquitinlik
protein
ubl
potent
antivir
similar
ubiquitin
coval
modifi
cellular
viral
substrat
follow
activ
enzym
conjug
enzym
ligat
three
identifi
enzym
isopeptidas
deconjug
howev
also
major
neg
regul
stat
signal
independ
effect
canon
induct
occur
follow
type
interferon
activ
viral
infect
howev
also
induc
varieti
stimuli
retino
acid
lp
genotox
addit
upregul
interferonindepend
manner
follow
infect
bacteri
pathogen
listeria
monocytogen
mycobacterium
murin
model
defici
studi
human
cell
line
demonstr
isgyl
broadli
target
numer
anim
develop
normal
suscept
viral
bacteri
pathogen
upon
furthermor
mani
virus
express
deconjugas
nonstructur
protein
prevent
conjug
suggest
evolutionari
pressur
dismantl
isgyl
effect
viral
vein
isopeptidas
dead
mutant
lead
enhanc
isgyl
follow
induct
resist
viral
infect
suscept
bacteri
infect
despit
initi
identif
antivir
molecul
patient
lack
appear
overli
sensit
viral
infect
instead
difficulti
clear
bacteri
infect
bcg
vaccin
due
reduc
interferon
gamma
patient
lack
also
develop
interferonopathi
report
origin
destabil
due
role
stat
signal
addit
function
three
distinct
mode
action
like
play
complementari
role
variou
tissu
follow
infect
secret
act
antivir
effect
noncoval
isgyl
also
reduc
viral
replic
viral
load
coval
modif
viral
andor
cellular
contrast
ubiquitin
mechanist
consequ
isgyl
fulli
elucid
howev
sever
gener
theme
emerg
regard
function
modifi
nascent
viral
protein
cotransl
therebi
interf
virion
isgyl
cellular
protein
alter
traffick
reduc
viral
bud
exosom
secret
increas
canon
cytokin
final
also
sever
instanc
isgyl
compet
ubiquitin
temporarili
stabil
protein
would
otherwis
order
better
understand
consequ
modif
protein
fate
systemat
identifi
endogen
substrat
follow
infect
vivo
bacteri
pathogen
listeria
monocytogen
enrich
peptid
remnant
left
posttransl
modif
trypsin
digest
coupl
identif
precis
site
modif
mass
spectrometri
extrem
fruit
unravel
mechan
action
modif
sever
studi
identifi
isgyl
target
approach
primarili
reli
either
ectop
express
tissu
cultur
cell
could
lead
overexpress
artifact
interferon
treatment
primari
cell
could
deliv
stronger
stimulu
physiolog
induc
viral
bacteri
infect
challeng
differenti
ubiquitin
site
ubl
share
diglycin
adduct
follow
digest
trypsin
recent
studi
use
distinct
immunoenrich
strategi
purifi
ubiquitin
site
howev
thu
far
one
abl
specif
identifi
isgyl
site
either
vitro
vivo
address
obstacl
defin
quantit
proteomewid
ubiquitylom
anim
prior
follow
infect
highlight
site
aris
listeria
infect
wildtyp
anim
well
mice
enhanc
isgyl
due
knock
inact
deconjugas
strategi
reveal
endogen
site
substrat
liver
context
clinic
relev
infect
unlik
sumoyl
neither
discern
consensu
motif
modif
enrich
modif
site
specif
cellular
compart
interestingli
modifi
metabol
enzym
lysin
dimer
interfac
catalyt
site
liver
particular
isgyl
target
four
key
regul
autophagi
lead
upregul
pathway
follow
infect
vivo
vitro
order
elucid
mechan
action
use
mass
spectrometri
ms
base
proteom
identifi
modif
site
unbias
manner
analyz
liver
tissu
mice
infect
listeria
monocytogen
enrich
peptid
carri
diglycin
adduct
follow
digest
trypsin
distinguish
bona
fide
isgyl
site
ubiquitin
site
share
conserv
ctermin
lrlrgg
motif
fig
compar
wildtyp
wt
mice
mice
ko
addit
map
site
mice
bear
knockin
ki
mutat
render
catalyt
inact
lead
hyperisgyl
follow
infect
condit
biolog
interest
addit
posit
control
screen
fig
two
distinct
mechan
action
remov
substrat
ii
neg
regul
stat
sinc
delet
distinguish
function
first
assess
whether
deconjugasedead
mous
would
resist
listeria
infect
mice
exhibit
increas
resist
viral
infect
otherwis
phenotyp
indistinguish
wildtyp
howev
surprisingli
listeria
infect
mice
lead
signific
increas
bacteri
load
liver
rel
wildtyp
control
fig
also
slight
signific
increas
bacteri
burden
spleen
anim
bacteri
count
liver
indic
unusu
suscept
organ
histolog
section
infect
liver
reveal
larger
diffus
bacteri
foci
penetr
neighbor
hepatocyt
anim
wherea
wildtyp
anim
bacteria
primarili
contain
within
immun
cell
fig
addit
gram
stain
confirm
presenc
mani
bacteria
per
focu
rel
wildtyp
anim
cfu
per
organ
indic
fig
accordingli
liver
tissu
infect
mice
also
display
enhanc
isgyl
compar
wt
fig
togeth
data
indic
tissuespecif
role
isgyl
liver
upon
listeria
infect
provid
rational
map
site
liver
anim
compar
wildtyp
anim
consequ
proteom
analysi
infect
wildtyp
mice
via
intraven
inject
harvest
liver
tissu
follow
h
infect
also
includ
noninfect
cohort
upon
trypsin
digest
enrich
diglycin
adduct
liver
diglycinemodifi
peptid
identifi
quantifi
follow
statist
analysi
nonsupervis
hierarch
cluster
significantli
regul
site
group
four
major
cluster
moreov
anim
also
cluster
togeth
genotyp
condit
indic
high
reproduc
approach
fig
prior
infect
ubiquitin
site
identifi
across
three
condit
cluster
listeria
infect
led
global
downregul
ubiquitin
site
previous
observ
ubiquitin
sumo
modif
also
identifi
ubiquitin
site
aris
follow
infect
cluster
importantli
abl
identifi
site
protein
induc
listeria
infect
cluster
major
site
complet
absent
anim
indic
gray
fig
right
panel
therefor
consid
bona
fide
site
also
identifi
site
protein
primarili
present
anim
cluster
sinc
concomitantli
induc
follow
listeria
infect
suspect
certain
substrat
deconjug
rapidli
other
futur
work
address
hypothesi
site
identif
time
cours
avoid
mistakenli
identifi
ubiquitin
site
site
due
possibl
indirect
effect
delet
mutat
assess
whether
ubiquitin
level
appear
vari
use
sdspage
prior
follow
infect
supplementari
fig
b
anyth
ubiquitin
site
decreas
follow
infect
vivo
isgyl
increas
previous
observ
new
observ
supplementari
fig
vitro
total
ubiquitin
dramat
chang
mous
embryon
fibroblast
h
post
infect
wherea
slightli
reduc
supplementari
fig
furthermor
comparison
site
identifi
quantit
diglycin
enrich
wildtyp
anim
prior
infect
show
significantli
regul
site
supplementari
fig
taken
togeth
data
suggest
site
identifi
method
like
bone
fide
site
extens
misidentifi
ubiquitin
site
ultim
identifi
site
protein
cluster
supplementari
data
previous
identifi
fig
supplementari
data
taken
togeth
approach
systemat
identifi
endogen
modif
site
vivo
analysi
primari
amino
acid
sequenc
identifi
site
reveal
obviou
amino
acid
consensu
sequenc
modif
fig
case
unlik
one
propos
mode
action
cotransl
modif
nascent
polypeptid
follow
viral
infect
mediat
ifninduc
sinc
listeria
provok
induct
interferonindepend
manner
assess
whether
potenti
bia
toward
isgyl
protein
induc
infect
could
correl
cotransl
modif
determin
quantit
proteom
input
supplementari
fig
supplementari
data
comparison
ubiquitin
protein
suggest
lower
percentag
modif
infectioninduc
target
infectioninduc
ubiquitin
target
fig
worthwhil
mechanist
determin
whether
listeria
infect
lead
similar
reduc
level
cotransl
modif
rel
viral
infect
futur
studi
date
modif
site
identifi
ubiquitin
howev
one
import
caveat
diglycin
enrichmentbas
studi
exclud
site
therefor
compar
publish
ubiquitin
identifi
site
fig
order
assess
overlap
site
could
aris
competit
ubiquitin
misidentifi
ubiquitin
site
first
site
identifi
prior
infect
screen
anim
therefor
expect
ubiquitin
site
overlap
publish
ubiquitin
site
ubiquitin
site
induc
infect
present
anim
overlap
publish
ubiquitin
site
notabl
site
identifi
condit
deregul
isgyl
overlap
ubiquitin
site
wherea
site
aros
wildtyp
anim
follow
listeria
infect
overlap
futur
biochem
analysi
site
competit
distinct
posttransl
modif
specif
substrat
critic
teas
apart
distinct
function
ubiquitin
condit
also
compar
site
identifi
acetyl
site
percentag
common
site
acetyl
cluster
similar
site
respect
wherea
site
induc
follow
infect
listeria
wildtyp
mice
cluster
overlap
acetyl
previou
work
indic
acetyl
preferenti
target
metabol
activ
enzym
acetyl
specif
enzym
distinct
effect
depend
enzym
tempt
specul
isgyl
could
compet
lysin
enzym
would
otherwis
activ
acetyl
infect
thwart
bacteri
acquisit
host
nutrient
taken
togeth
isgyl
follow
listeria
infect
show
signific
overlap
ubiquitin
acetyl
suggest
competit
specif
lysin
gene
ontolog
analysi
isgyl
protein
cellular
compart
highlight
signific
enrich
extracellular
protein
infect
condit
fig
result
support
publish
role
isgyl
exosom
secret
well
find
isgyl
modul
cytokin
secret
highlight
potenti
substrat
addit
could
potenti
affect
identifi
isgylom
follow
listeria
infect
wildtyp
anim
significantli
enrich
mitochondri
protein
liver
tissu
fig
recent
work
indic
affect
mitochondri
morpholog
function
follow
vaccinia
viru
infect
identif
enrich
mitochondri
protein
isgyl
follow
listeria
infect
concord
gene
ontolog
analysi
isgyl
protein
molecular
function
reveal
enrich
protein
bind
nucleotid
atp
wildtyp
condit
fig
follow
infect
wildtyp
anim
enrich
isgyl
cofactor
coenzymebind
protein
well
lyas
activ
absent
anim
enhanc
isgyl
addit
gene
ontolog
analysi
isgyl
protein
biolog
process
reveal
strike
enrich
number
differ
metabol
pathway
includ
adp
glutathion
glucos
metabol
well
lipid
oxid
fig
taken
togeth
modifi
number
protein
liver
relev
control
metabol
primari
goal
identifi
site
determin
strict
ubiquitylom
allow
us
gain
insight
ubiquitin
modif
cooper
infect
inde
immedi
appar
larg
number
ubiquitin
site
cluster
disappear
follow
infect
other
emerg
like
follow
transcript
upregul
ubiquitin
substrat
fig
b
supplementari
fig
supplementari
data
interestingli
also
found
evid
modif
ubiquitin
modif
wildtyp
infect
condit
ki
mice
fig
analysi
formal
differenti
modif
ubiquitin
sinc
absent
strict
ubiquitylom
design
howev
data
confirm
ubiquitin
modifi
mix
chain
ubiquitin
previous
identifi
modif
fig
yet
describ
whether
repres
mix
chain
ubiquitin
chain
remain
determin
futur
biochem
studi
consequ
natur
chain
follow
infect
like
worthwhil
gene
ontolog
analysi
ubiquitin
site
gain
lost
follow
infect
cluster
respect
reveal
certain
substrat
similarli
enrich
among
ubiquitin
target
site
nucleotid
bind
cellular
metabol
process
howev
other
invers
correl
site
cofactor
bind
coenzym
bind
lyas
ligas
activ
fig
pattern
enrich
suggest
certain
ubiquitin
modif
replac
modif
follow
infect
interestingli
site
protein
relat
metabol
process
significantli
enrich
among
ubiquitin
site
suggest
isgyl
specif
target
protein
affect
metabol
wherea
ubiquitin
sever
group
substrat
associ
respons
pathogen
cell
death
translat
differenti
ubiquitin
site
site
discern
primari
amino
acid
sequenc
motif
site
hypothes
might
specif
domain
structur
featur
target
ubl
therefor
focus
site
protein
known
crystal
structur
search
common
featur
surround
identifi
target
lysin
sever
case
modif
occur
site
proteinprotein
interact
sever
protein
complex
fig
dimer
interfac
fig
fact
mammalian
target
rapamycin
mtor
modifi
lysin
follow
infect
listeria
wildtyp
anim
within
fkbp
rapamycinbind
mtor
critic
immun
respons
pathogen
also
neg
regul
catabol
process
autophagi
target
bacteria
degrad
lysosom
second
autophagi
regul
rasrel
protein
also
emerg
analysi
target
modifi
condit
deregul
autophagi
ki
mice
notabl
modifi
close
proxim
gtpbind
domain
case
isgyl
occur
near
gtpbind
site
activ
site
enzym
fig
modif
bulki
diubiquitinlik
molecul
site
could
potenti
hinder
enzymat
activ
gtpase
function
proxim
target
lysin
domain
significantli
closer
lysin
structur
supplementari
fig
systemat
gene
ontolog
analysi
reveal
enrich
nucleotid
atpbind
protein
well
cofactor
coenzymebind
protein
fig
molecular
function
panel
addit
mani
metabol
enzym
isomeras
phosphoglycer
kinas
also
modifi
follow
infect
listeria
either
dimer
domain
activ
site
enzym
fig
taken
togeth
isgyl
liver
enzym
modul
growth
factor
signal
catabol
pathway
suggest
new
role
isgyl
liver
metabol
infect
struck
modif
four
key
regul
autophagi
isgyl
particular
modif
mtor
follow
infect
wildtyp
anim
follow
listeria
infect
modif
follow
infect
anim
given
particular
relev
protein
control
autophagi
explor
whether
pathway
alter
upon
listeria
infect
autophagi
catabol
cellular
respons
starvat
also
control
target
intracellular
pathogen
lysosom
degrad
indirectli
alter
pathogen
access
cytosol
nutrient
requir
growth
replic
listeria
express
acta
evad
autophagi
spread
recent
work
suggest
acta
level
plung
bacterium
trap
replic
vacuol
hepatocyt
process
could
potenti
involv
autophag
reason
either
pathway
could
affect
alter
autophagi
induct
anim
cell
modif
enhanc
order
address
question
gener
mous
embryon
fibroblast
mef
wildtyp
anim
first
assess
isgyl
level
wildtyp
versu
cell
follow
interferon
treatment
found
level
isgyl
mef
rel
wildtyp
much
higher
expect
fig
surprisingli
longer
exposur
use
film
reveal
increas
isgyl
prior
interferon
treatment
well
supplementari
fig
took
advantag
unexpect
increas
isgyl
fibroblast
mimic
vivo
isgyl
follow
listeria
infect
hyperisgyl
protect
listeria
infect
wildtyp
isgyl
tissu
cultur
cell
contrast
fibroblast
highli
suscept
listeria
infect
fig
fact
upon
normal
bacteri
load
across
experi
evid
bimod
distribut
suggest
subset
cell
hyperisgyl
protect
wildtyp
isgyl
cell
intrins
manner
similar
report
viral
find
support
previou
work
demonstr
overexpress
protect
listeria
infect
nonphagocyt
next
sought
quantifi
autophagi
cell
assess
endogen
convers
autophag
marker
via
sdspage
analysi
fig
autophagi
dramat
upregul
fibroblast
rel
wildtyp
cell
prior
infect
baselin
autophag
flux
assess
addit
bafilomycin
inhibit
lysosom
acidif
infect
listeria
induc
autophagi
wildtyp
cell
howev
induct
dramat
significantli
increas
cell
enhanc
isgyl
fig
furthermor
autophagi
adaptor
also
target
degrad
autophagi
reduc
quantiti
mef
rel
wildtyp
mef
baselin
degrad
follow
listeria
infect
degrad
could
partial
complet
halt
bafilomycin
treatment
fig
interestingli
delet
also
increas
autophagi
previous
howev
accumul
condit
thu
seem
target
autophagosom
lysosom
may
impair
cell
fig
subsequ
ectop
express
autophag
marker
wildtyp
fibroblast
quantifi
basal
autophagi
well
autophagi
follow
infect
enumer
puncta
fig
e
across
condit
significantli
puncta
per
cell
fibroblast
wildtyp
cell
wherea
cell
display
intermedi
phenotyp
significantli
differ
either
wildtyp
cell
increas
bafilomycin
treat
cell
support
impair
traffick
final
wonder
whether
effect
autophagi
induct
would
also
occur
vivo
follow
listeria
infect
assess
level
liver
homogen
isol
wildtyp
anim
follow
h
infect
found
increas
well
anim
fig
taken
togeth
predict
global
isgylom
analysi
modif
key
modul
autophagi
led
increas
basal
infectioninduc
activ
pathway
cell
anim
enhanc
isgyl
order
determin
whether
modif
autophagi
regul
direct
effect
turnov
chose
focu
mtor
sinc
play
critic
role
growth
metabol
target
mtor
lie
fkpbrapamycinbind
domain
frb
fig
b
order
valid
modif
mtor
transfect
cell
fig
isgyl
mtor
visibl
follow
transfect
immunoprecipit
wildtyp
mutant
unabl
conjug
addit
valid
modif
myosin
isomeras
supplementari
fig
sinc
overexpress
system
report
lead
promiscu
cotransl
modif
access
endeavor
valid
endogen
modif
mtor
mef
treat
ifn
model
vivo
infect
upon
immunoprecipit
endogen
mtor
clear
doublet
correspond
present
wildtyp
mef
fig
probe
immunoprecipit
mtor
antibodi
ubiquitin
reveal
modif
protein
valid
identif
bone
fide
site
approach
supplementari
fig
doublet
could
repres
two
individu
monoisgyl
site
chain
molecul
given
observ
site
sinc
quantifi
one
modif
site
mtor
mutat
lysin
arginin
assess
effect
mutat
autophagi
induct
human
hepatocellular
carcinoma
cell
fig
amino
acid
starvat
cell
led
increas
expect
ectop
express
mtor
induc
rel
less
wildtyp
mtor
mock
transfect
cell
indic
isgyl
mtor
could
repress
activ
observ
howev
made
cell
harbor
endogen
mtor
therefor
futur
work
assess
effect
geneedit
kr
mutant
absenc
wildtyp
mtor
well
substrat
analysi
interest
mechanist
assess
effect
isgyl
specif
target
lysin
taken
togeth
mtor
isgyl
lysin
liver
listeriainfect
anim
valid
modif
occur
vitro
human
mous
cell
mutat
lysin
arginin
repress
effect
downstream
process
autophagi
overexpress
model
human
liver
cell
devis
strategi
combin
murin
model
defici
enhanc
isgyl
quantit
labelfre
proteom
map
endogen
liver
isgylom
anim
infect
bacteri
pathogen
listeria
monocytogen
identifi
distinguish
bona
fide
isgyl
site
ubiquitin
site
vivo
map
site
protein
substanti
increas
previou
studi
conjug
addit
observ
modif
occur
known
acetyl
site
follow
infect
extracellularsecret
mitochondri
protein
observ
modif
target
metabol
pathway
comput
analysi
avail
structur
target
protein
highlight
often
modifi
site
protein
dimer
catalyt
site
enzym
valid
find
assess
role
modif
known
regul
catabol
process
autophagi
found
basal
infectioninduc
autophagi
increas
cell
anim
enhanc
isgyl
enrich
adduct
specif
posttransl
modif
left
follow
trypsin
digest
revolution
understand
ubiquitin
code
acetylom
help
systemat
identifi
sumoylom
challeng
studi
due
absenc
genet
tractabl
model
organ
yeast
multipl
mode
action
cytokin
coval
modif
noncoval
interact
absenc
prior
induct
follow
infect
ctermin
lrlrgg
motif
indistinguish
ubiquitin
initi
identif
substrat
follow
ectop
express
enrich
affin
purif
suggest
widespread
rel
promiscu
modif
proteom
either
human
cell
mous
cell
defici
howev
studi
reli
ectop
express
well
substrat
treatment
interferon
tissu
cultur
cell
condit
may
reflect
nativ
induct
isgyl
context
infect
whole
organ
sinc
largescal
quantit
isgylom
publish
contribut
largescal
map
endogen
site
relev
infect
set
vivo
furthermor
strategi
allow
us
determin
strict
ubiquitylom
liver
tissu
anim
prior
follow
infect
listeria
monocytogen
order
identifi
isgylom
vivo
ubiquitylom
follow
listeria
infect
yet
map
similar
observ
cell
listeria
provok
downregul
mani
ubiquityl
addit
data
confirm
exist
mix
chain
vivo
ubiquitin
previous
report
potenti
yet
analysi
also
reveal
site
possibl
chain
function
remain
explor
method
led
identif
site
protein
follow
infect
wildtyp
anim
site
protein
anim
total
identifi
site
site
follow
listeria
infect
percentag
indic
less
abund
modif
sumo
ubiquitin
line
previou
howev
number
site
also
impli
previous
identifi
ubiquitin
site
may
fact
misidentifi
site
follow
vitro
viral
infect
interferon
treatment
overexpress
along
target
cotransl
modif
data
suggest
listeria
infect
vivo
modif
infectioninduc
protein
constitut
around
modifi
protein
wildtyp
infect
cluster
enhanc
isgyl
cluster
contrast
ubiquitin
substrat
protein
modifi
also
upregul
infect
cluster
inform
assess
whether
viral
infect
caus
higher
rate
infectioninduc
protein
modif
bacteri
infect
whether
phenomenon
vari
one
tissu
cell
type
anoth
approach
took
advantag
anim
howev
one
potenti
caveat
could
lack
provok
compensatori
chang
ubiquitin
site
level
attempt
assess
possibl
sdspage
quantit
proteom
diglycin
site
prior
infect
find
substant
differ
wildtyp
howev
use
newli
avail
method
ubisit
assess
ubiquitin
level
anim
cell
would
definit
address
recent
eleg
biochem
studi
character
viral
effector
call
lb
pro
footandmouthdiseaseviru
reveal
function
isopeptidas
also
exploit
identifi
one
potenti
challeng
use
viral
protein
identifi
site
lie
control
demonstr
specif
ubiquitin
thu
futur
studi
compar
substrat
method
would
time
relev
identifi
core
list
site
well
site
could
potenti
uniqu
specif
biolog
condit
infect
data
set
reveal
mani
unexpect
find
also
confirm
previous
describ
observ
cellular
compart
particularli
enrich
across
cluster
extracellular
secret
protein
support
role
exosom
secret
though
specif
identifi
substrat
follow
listeria
concomitantli
upregul
follow
listeria
infect
whether
tempor
regul
specif
target
alter
stat
signal
remain
determin
therefor
isgylom
could
potenti
repres
distinct
subset
substrat
could
hypothet
need
rapidli
remov
cours
infect
proper
antibacteri
immun
thu
cluster
protein
present
wildtyp
absent
follow
infect
like
closest
approxim
wildtyp
isgylom
follow
listeria
infect
cluster
display
increas
overlap
known
acetyl
site
well
modif
mitochondri
protein
protein
acetyl
nucleu
cytosol
mitochondria
control
varieti
cellular
function
gene
express
metabol
pathway
modul
nad
depend
protein
deacetylas
previou
work
highlight
import
histon
deacetyl
sirtuin
transcript
reprogram
infect
current
work
impli
sirtuin
could
also
import
metabol
reprogram
concert
competit
isgyl
one
enigmat
find
literatur
presenc
isgyl
conjug
within
mitochondria
determin
protect
chain
proteinas
k
least
site
mitochondri
protein
identifi
locat
within
inner
mitochondri
membran
occur
topolog
remain
elucid
gene
ontolog
analysi
also
unearth
enrich
cofactor
nucleotidebind
protein
varieti
metabol
pathway
sinc
find
particular
motif
either
cluster
analyz
topographi
solv
protein
structur
surround
modifi
lysin
sever
case
site
dimer
target
activ
site
enzym
liver
site
immun
surveil
metabol
activ
detoxif
blood
therefor
isgyl
may
uniqu
modif
transmit
alarm
signal
bacteri
viral
infect
metabol
consequ
modif
site
dimer
activ
site
metabol
enzym
reduc
activ
enzym
could
anoth
tool
arsen
pathogen
otherwis
could
usurp
cellular
metabolit
surviv
replic
intrigu
modif
autophagi
modul
mtor
modif
mtor
fkbprapamycinbind
domain
could
act
repress
function
growth
metabol
upregul
process
xenophagi
effect
mtor
mutant
autophagi
induct
would
support
hypothesi
howev
previous
mention
effect
observ
presenc
wildtyp
mtor
futur
work
delet
knockdown
background
even
inform
consequ
modif
site
difficult
predict
given
less
known
regard
structur
featur
assess
gener
autophagi
level
follow
infect
inde
basal
infectioninduc
autophagi
increas
cell
anim
rel
wildtyp
previou
work
report
modif
autophagi
regul
howev
specif
modif
appear
occur
listeria
infect
within
cell
elev
autophagi
led
wildtyp
slightli
better
clearanc
bacteria
would
predict
howev
cell
extrins
role
mutat
vivo
led
higher
bacteri
load
potenti
previous
report
pleiotrop
effect
signal
cytokin
secret
could
favor
listeria
replic
follow
uncheck
isgyl
futur
work
tackl
discrep
assess
rel
contribut
cytokin
secret
versu
autophagi
induct
bacteri
burden
vivo
taken
togeth
gener
comprehens
map
site
pave
way
understand
consequ
modif
protein
fate
function
addit
strategi
establish
provid
previous
unavail
tool
global
identifi
endogen
pathogenderiv
isgyl
substrat
within
context
whole
organ
use
antibodi
santa
cruz
antibodi
abcam
uk
use
antibodi
mbl
japan
clone
antibodi
sigma
saint
loui
mo
use
antibodi
sigma
immunoprecipit
antibodi
cell
signal
antibodi
sigma
antibodi
cell
signal
antibodi
cell
signal
use
antibodi
sigma
immunoblot
antibodi
santa
cruz
biotechnolog
use
antibodi
sigma
tag
grade
abcam
uk
antibodi
genetex
use
antibodi
magnet
bead
pierc
antiflag
antibodi
magnet
bead
sigma
millipor
immunoprecipit
listeria
monocytogen
strain
egd
bug
use
infect
studi
listeria
grown
brain
heart
infus
media
bd
prior
infect
overnight
cultur
bacteri
strain
dilut
new
media
grown
exponenti
phase
od
wash
three
time
serumfre
mammalian
cell
cultur
media
resuspend
mammalian
cell
cultur
media
indic
moi
fix
volum
ad
well
cell
centrifug
min
g
synchron
infect
cell
incub
bacteria
h
follow
incub
cell
wash
room
temperatur
pb
cell
growth
medium
serum
ad
gentamicin
kill
extracellular
bacteria
cell
harvest
indic
time
point
collect
bacteria
colonyform
unit
collect
protein
lysat
sdspage
analysi
mous
embryon
fibroblast
grown
dmem
glutamax
gibco
waltham
supplement
fetal
bovin
serum
primari
mous
embryon
fibroblast
transform
transfect
fugen
hd
promega
plasmid
contain
larg
antigen
retroviru
gener
transfect
phoenix
cell
atcc
pbabe
puro
plasmid
list
supplementari
data
use
fugen
hd
ml
collect
viru
mix
condit
media
mef
supplement
polybren
millipor
appli
mef
viru
collect
appli
mef
presenc
polybren
millipor
describ
protocol
product
retrovirus
use
fugen
weinberg
lab
addgen
cell
select
use
puromycin
day
popul
cell
surviv
puromycin
treatment
expand
test
express
mainten
cell
initi
grown
without
puromycin
howev
observ
cell
would
lose
express
time
like
due
deleteri
level
autophagi
therefor
requir
maintain
cell
puromycin
cell
obtain
laboratori
elian
meur
institut
pasteur
transfect
fugen
hd
promega
mycmtor
mycmtor
fortyeight
hour
post
transfect
cell
starv
without
amino
acid
hbss
medium
h
cell
treat
bafilomycin
nm
min
subsequ
lyse
ripa
lysi
buffer
supplement
complet
mini
proteas
inhibitor
cocktail
roch
obtain
prof
sven
eyckerman
hela
obtain
cell
grown
confluenc
dmem
fb
ps
transfect
use
polyethylenimin
pei
h
transfect
anoth
h
h
plasmid
use
origen
supplementari
data
cell
line
test
mycoplasma
prior
expans
laboratori
subsequ
time
per
year
exhibit
symptom
slow
growth
increas
cell
death
follow
transfect
infect
use
iclac
cell
line
studi
two
cell
line
hela
authent
pcr
singlelocu
technolog
eurofin
march
sdspage
analysi
fibroblast
cell
trypsin
trypsin
invitrogen
lyse
triton
lysi
buffer
supplement
complet
mini
proteas
inhibitor
cocktail
roch
gel
transfer
use
iblot
transfer
system
invitrogen
block
milk
hr
rt
incub
primari
antibodi
overnight
wash
tween
pb
three
time
wash
min
incub
h
room
temperatur
secondari
antibodi
coupl
hrp
blot
wash
three
time
tween
pb
reveal
use
ecl
western
blot
substrat
pierc
waltham
cell
lyse
protein
concentr
determin
either
bradford
bca
assay
total
mg
total
protein
use
either
flag
gfp
haimmunoprecipit
use
affin
gel
merck
ha
isol
kit
milteni
biotec
antiha
magnet
bead
pierc
chromotek
accord
manufactur
instruct
expand
mous
embryon
fibroblast
dish
per
genotyp
six
dish
genotyp
treat
recombin
mous
type
interferon
ifnalpha
protein
r
system
uml
h
six
dish
untreat
h
posttreat
cell
lyse
ml
ripa
lysi
buffer
per
dish
lysat
six
dish
combin
condit
treat
univers
nucleas
h
pierc
centrifug
pellet
discard
protein
concentr
lysat
measur
use
bca
assay
pierc
mg
protein
condit
use
subsequ
immunoprecipit
sampl
incub
mtor
antibodi
h
antibodymix
sampl
incub
slurri
protein
ag
magnet
agaros
bead
thermo
scientif
h
bead
pull
magnet
dyna
invitrogen
wash
three
time
cold
pb
protein
elut
bead
glycin
ph
immedi
neutral
alkalin
neutral
buffer
ph
eluat
reduc
sampl
buffer
supplement
heat
min
cell
plate
coverslip
day
prior
experi
cell
fix
pfa
electron
microscopi
scienc
hatfield
pennsylvania
pb
min
room
temperatur
coverslip
mount
use
prolong
diamond
antifad
mount
media
thermo
fisher
scientif
usa
imag
acquir
use
invert
widefield
fluoresc
microscop
axio
observ
carl
zeiss
microscopi
germani
equip
axiocam
mono
camera
softwar
zen
pro
imag
process
use
autocontrast
renyi
entropi
threshold
preset
optim
resolut
puncta
count
use
particl
analyz
function
size
threshold
pixel
puncta
enumer
divid
per
nuclei
within
field
least
cell
count
per
experi
data
compil
three
independ
experi
statist
analysi
conduct
use
oneway
anova
tukey
test
post
hoc
femal
mice
infect
intraven
week
age
bacteria
per
anim
sacrif
h
follow
infect
colonyform
unit
per
organ
liver
spleen
enumer
tissu
dissoci
serial
dilut
steril
salin
sdspage
anim
sampl
wildtyp
mice
infect
intraven
listeria
inject
steril
salin
solut
sacrif
h
liver
spleen
isol
dissoci
tissu
homogen
centrifug
g
min
liver
tissu
aliquot
solubl
fraction
layer
fat
remov
resuspend
laemmli
buffer
sampl
run
sdspage
gel
blot
actin
level
determin
statist
signific
anim
experi
nonparametr
analys
use
sinc
n
low
determin
normal
distribut
use
twotail
test
exact
pvalu
display
enumer
punta
vitro
infect
assay
use
oneway
anova
follow
tukey
test
post
hoc
statist
method
proteom
analysi
discuss
proteom
method
studi
carri
strict
accord
french
nation
european
law
conform
council
direct
approxim
law
regul
administr
provis
member
state
regard
protect
anim
use
experiment
scientif
purpos
experi
reli
laboratori
anim
perform
strict
accord
institut
pasteur
regul
anim
care
use
protocol
approv
anim
experi
committe
institut
pasteur
approv
number
three
mice
per
genotyp
per
condit
inject
intraven
listeria
monocytogen
strain
egd
pb
carrier
control
monitor
weigh
daili
seventytwo
hour
post
infect
anim
sacrif
whole
liver
collect
flashfrozen
liquid
nitrogen
liver
homogen
ml
urea
lysi
buffer
contain
urea
mm
hepe
ph
mm
sodium
orthovanad
mm
sodium
pyrophosph
mm
sampl
sonic
three
puls
amplitud
centrifug
min
g
room
temperatur
remov
insolubl
compon
protein
concentr
supernat
replic
measur
use
bradford
assay
biorad
equal
protein
amount
contain
mg
total
protein
use
analysi
protein
sampl
reduc
ad
mm
dtt
incub
min
alkyl
protein
done
addit
mm
chloroacetamid
min
room
temperatur
dark
sampl
dilut
mm
hepe
ph
urea
concentr
protein
digest
trypsin
promega
ww
overnight
immunocaptur
ggmodifi
peptid
perform
use
ubiquitin
remnant
motif
kit
cell
signal
technolog
accord
manufactur
instruct
briefli
peptid
purifi
seppak
cartridg
water
lyophil
day
redissolv
ml
immunoprecipit
buffer
suppli
kit
note
point
aliquot
correspond
digest
protein
materi
taken
shotgun
proteom
analysi
peptid
incub
antibodybead
slurri
h
rotat
sever
wash
step
ggmodifi
peptid
elut
tfa
desalt
revers
phase
omix
tip
agil
accord
manufactur
protocol
purifi
ggmodifi
peptid
dri
vacuum
hplc
insert
store
lcmsm
analysi
purifi
ggmodifi
peptid
redissolv
load
solvent
tfa
wateracn
vv
inject
lcmsm
analysi
ultim
rslcnano
system
inlin
connect
q
exact
hf
mass
spectromet
thermo
trap
perform
min
load
solvent
mm
trap
column
made
inhous
intern
diamet
id
bead
reprosilhd
dr
maisch
germani
sampl
load
mm
analyt
column
made
inhous
id
bead
reprosilhd
dr
maisch
peptid
elut
nonlinear
increas
ms
solvent
b
fa
wateracetonitril
vv
min
constant
flow
rate
nlmin
follow
wash
reach
ms
solvent
b
reequilibr
ms
solvent
fa
wateracetonitril
vv
column
temperatur
kept
constant
column
oven
cocontrol
sonat
mass
spectromet
oper
datadepend
mode
automat
switch
ms
msm
acquisit
abund
ion
peak
per
ms
spectrum
fullscan
ms
spectra
mz
acquir
resolut
orbitrap
analyz
accumul
target
valu
intens
ion
threshold
valu
isol
fragment
normal
collis
energi
fill
trap
target
valu
maximum
ms
msm
spectra
mz
acquir
resolut
orbitrap
analyz
aliquot
shotgun
proteom
analysi
peptid
inject
lcmsm
system
use
similar
set
describ
intens
ion
threshold
valu
isol
fragment
fill
trap
target
valu
maximum
ms
data
analysi
perform
maxquant
version
use
andromeda
search
engin
default
search
set
includ
fals
discoveri
rate
set
peptid
protein
level
two
differ
search
perform
analyz
spectra
ggenrich
sampl
shotgun
sampl
search
spectra
interrog
mous
protein
uniprotswissprot
databas
databas
releas
version
may
contain
mous
protein
sequenc
wwwuniprotorg
well
protein
l
monocytogen
strain
egd
taxonomi
id
contain
listeria
sequenc
http
wwwncbinlmnihgov
mass
toler
precursor
ion
ppm
mass
toler
fragment
ion
ppm
da
ggenrich
shotgun
sampl
respect
enzym
specif
set
ctermin
arginin
lysin
trypsin
also
allow
cleavag
bond
maximum
three
miss
cleavag
ggenrich
sampl
maximum
two
miss
cleavag
shotgun
sampl
carbamidomethyl
cystein
residu
set
fix
modif
search
variabl
modif
set
oxid
methionin
sulfoxid
acetyl
protein
ntermini
minimum
score
modifi
peptid
set
ggenrich
sampl
glygli
modif
lysin
residu
set
addit
variabl
modif
search
match
run
enabl
align
time
window
min
match
time
window
min
shotgun
analysi
protein
least
one
uniqu
razor
peptid
retain
lead
identif
mous
protein
list
proteingroup
tabl
ggenrich
sampl
potenti
ubiquitin
site
list
glygli
k
site
tabl
identifi
data
analysi
perform
perseu
softwar
version
load
glygli
k
site
tabl
maxquant
revers
databas
hit
remov
well
potenti
contamin
site
tabl
expand
intens
transform
normal
sampl
subtract
median
intens
replic
sampl
group
site
less
three
valid
valu
least
one
group
remov
miss
valu
imput
normal
distribut
around
detect
limit
reveal
site
significantli
regul
sampl
group
defin
base
infect
uninfect
vs
egd
genotyp
wt
vs
vs
twoway
anova
test
perform
compar
intens
site
infect
group
genotyp
group
modif
site
test
calcul
pvalu
actual
pvalu
infect
pvalu
genotyp
total
site
pvalu
least
one
group
consid
significantli
regul
intens
site
shown
heatmap
fig
nonsupervis
hierarch
cluster
significantli
regul
modif
site
report
supplementari
data
reveal
ubiquitin
site
regul
infect
test
fdr
perform
compar
glygli
k
site
sampl
mice
quantifi
glygli
k
site
n
result
test
shown
fig
list
supplementari
data
analysi
shotgun
data
proteingroup
tabl
maxquant
load
perseu
revers
databas
hit
remov
well
protein
identifi
site
lfq
intens
transform
normal
sampl
subtract
median
lfq
intens
replic
sampl
group
protein
less
three
valid
valu
least
one
group
remov
miss
valu
imput
normal
distribut
around
detect
limit
reveal
protein
significantli
regul
sampl
group
similarli
describ
twoway
anova
test
perform
compar
lfq
intens
protein
infect
group
genotyp
group
total
protein
pvalu
least
one
group
consid
significantli
regul
lfq
intens
protein
shown
heatmap
supplementari
fig
nonsupervis
hierarch
cluster
significantli
regul
protein
report
supplementari
data
sinc
two
major
cluster
observ
heatmap
test
perform
fdr
compar
protein
intens
infect
noninfect
sampl
quantifi
protein
n
result
test
list
supplementari
data
shown
volcano
plot
fig
significantli
downregul
protein
test
use
calcul
percentag
site
overlap
known
ubiquitin
acetyl
site
fig
go
term
enrich
analys
perform
use
gene
ontolog
consortium
bioinformat
mass
spectrometri
proteom
data
deposit
proteomexchang
consortium
via
pride
partner
repositori
data
set
identifi
project
name
proteomicsbas
identif
modif
site
listeria
monocytogen
infect
ortholog
sequenc
protein
retriev
applic
program
interfac
api
access
use
dbclient
modul
python
http
githubcomlpryszczmetaphorsapi
one
set
ortholog
sequenc
compil
given
uniprot
protein
id
multipl
sequenc
align
perform
use
mafft
version
set
ortholog
sequenc
sequenc
conserv
comput
occurr
frequenc
ly
site
interest
among
given
set
ortholog
sequenc
name
speci
isgyl
retriev
ncbi
http
wwwncbinlmnihgovgen
structur
protein
retriev
protein
data
bank
pdb
use
uniprot
modul
http
pypiorgprojectuniprot
python
multipl
structur
avail
given
protein
structur
would
retriev
analyz
solvent
access
site
interest
comput
use
dssp
http
wwwcmbirunldssphtml
rel
solvent
access
rsa
comput
normal
solvent
access
maximum
allow
solvent
access
report
ref
protein
structur
render
visual
pymol
http
pymolorg
inform
research
design
avail
natur
research
report
summari
link
articl
